Arrien Investments’s Eli Lilly LLY Stock Holding History

Arrien Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$295K	Hold	246	–	–	0.15%	37
2026 Q1	$226K	Hold	246	–	–	0.12%	42
2025 Q4	$264K	Buy	+246	New	+$235K	0.15%	37
2025 Q2	–	Sell	-246	Closed	-$203K	–	42
2025 Q1	$203K	Hold	246	–	–	0.15%	33
2024 Q4	$203K	Sell	246 -65	-21%	-$53.8K	0.14%	36
2024 Q3	$276K	Sell	311 -27	-8%	-$24.3K	0.2%	31
2024 Q2	$306K	Hold	338	–	–	0.24%	30
2024 Q1	$263K	Sell	338 -133	-28%	-$94.7K	0.21%	36
2023 Q4	$275K	Hold	471	–	–	0.24%	31
2023 Q3	$253K	Sell	471 -33	-7%	-$17K	0.24%	31
2023 Q2	$236K	Sell	504 -246	-33%	-$103K	0.2%	36
2023 Q1	$258K	Buy	+750	New	+$253K	0.25%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrien Investments's LLY Position: Q2 2026 in Review

Arrien Investments held its Eli Lilly (LLY) position steady in Q2 2026 at 246 shares worth $295K. The position accounts for 0.15% of the portfolio, ranked #37.

Arrien Investments first reported a position in LLY in Q1 2023 and has held it in 12 quarters since. The position peaked at $306K in Q2 2024. 4,641 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Arrien Investments held 246 shares of Eli Lilly worth $295K as of Q2 2026.
Arrien Investments left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.15% of Arrien Investments's portfolio in Q2 2026, its #37 holding.
Arrien Investments first reported a position in Eli Lilly in Q1 2023 and has held it in 12 quarters since.
Arrien Investments's Eli Lilly position peaked at $306K in Q2 2024.
4,641 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arrien Investments's 13F filing for Q2 2026, filed 30 Jul 2026.